Lexicon Pharmaceuticals Inc (LXRX) — Net Asset Momentum
Lexicon Pharmaceuticals Inc (LXRX) recorded a net asset momentum of -26.3% as of December 2025, with net assets of $107.54 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See LXRX cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Lexicon Pharmaceuticals Inc Net Asset Momentum (1999–2025)
This chart tracks Lexicon Pharmaceuticals Inc's year-over-year net asset growth across 27 annual reporting periods from 1999 to 2025. The most recent momentum reading is -26.3%, with net assets of $107.54 Million USD as of December 2025. Read LXRX total debt and obligations for a breakdown of total debt and financial obligations.
Annual Net Asset History for Lexicon Pharmaceuticals Inc (1999–2025)
The table below shows the complete annual net asset history for Lexicon Pharmaceuticals Inc from 1999 to 2025, covering 27 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see LXRX market cap overview.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $107.54 Million | $184.99 Million | $77.45 Million | ▼ -26.3% |
| 2024 | $145.95 Million | $298.42 Million | $152.47 Million | ▲ +56.8% |
| 2023 | $93.11 Million | $229.43 Million | $136.32 Million | ▼ -20.5% |
| 2022 | $117.12 Million | $194.30 Million | $77.17 Million | ▲ +3.1% |
| 2021 | $113.59 Million | $136.91 Million | $23.31 Million | ▼ -27.4% |
| 2020 | $156.37 Million | $203.79 Million | $47.42 Million | ▲ +33.5% |
| 2019 | $117.10 Million | $417.71 Million | $300.61 Million | ▲ +543.5% |
| 2018 | $-26.41 Million | $284.14 Million | $310.54 Million | ▼ -150.7% |
| 2017 | $52.10 Million | $436.54 Million | $384.44 Million | ▼ -66.9% |
| 2016 | $157.40 Million | $475.62 Million | $318.22 Million | ▼ -44.9% |
| 2015 | $285.85 Million | $654.83 Million | $368.98 Million | ▲ +0.6% |
| 2014 | $284.02 Million | $471.38 Million | $187.36 Million | ▲ +66.9% |
| 2013 | $170.16 Million | $274.16 Million | $104.00 Million | ▼ -36.2% |
| 2012 | $266.68 Million | $371.78 Million | $105.10 Million | ▼ -10.4% |
| 2011 | $297.57 Million | $430.51 Million | $132.94 Million | ▲ +20.5% |
| 2010 | $247.02 Million | $366.88 Million | $119.86 Million | ▲ +51.1% |
| 2009 | $163.50 Million | $257.76 Million | $94.26 Million | ▼ -16.5% |
| 2008 | $195.83 Million | $261.51 Million | $65.68 Million | ▼ -31.7% |
| 2007 | $286.57 Million | $369.30 Million | $82.72 Million | ▲ +235.2% |
| 2006 | $85.50 Million | $190.27 Million | $104.77 Million | ▼ -0.4% |
| 2005 | $85.80 Million | $218.71 Million | $132.91 Million | ▼ -29.4% |
| 2004 | $121.59 Million | $211.98 Million | $90.39 Million | ▼ -26.8% |
| 2003 | $166.22 Million | $284.20 Million | $117.98 Million | ▼ -2.2% |
| 2002 | $169.90 Million | $201.77 Million | $31.87 Million | ▼ -22.2% |
| 2001 | $218.37 Million | $239.99 Million | $21.62 Million | ▲ +5.2% |
| 2000 | $207.63 Million | $220.69 Million | $13.06 Million | ▲ +2432.1% |
| 1999 | $8.20 Million | $22.30 Million | $14.10 Million | — |